Solutions Through Adv Rch /ID# 226104

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Psoriasis

Running trials

• Active, not recruiting

  Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

  NCT04862286· Phase 3· AbbVie· Source